Abstract:Background Neoadjuvant immunotherapy plus chemotherapy has shown satisfying efficacy and manageable safety in locally advanced esophageal squamous cell carcinoma (ESCC) patients. Tumor-infiltrating lymphocytes (TILs) have been shown to be associated with the prognosis of various cancer types. It is unknown whether these TILs-associated characteristics can be adopted as a reliable prognostic biomarker for immunotherapy-based regimen. The current study aimed to assess the prognostic power of spatial organization of TILs in patients with advanced ESCC treated with immunochemotherapy. Methods In this retrospective, multicenter cohort study, pathologically confirmed locally advanced ESCC that was potentially resectable after neoadjuvant immunochemotherapy were included. Image segmentation was performed using UNet++ algorithm and H&E-stained nuclei were segmented using the StarDist deep-learning image segmentation. For the nuclei classification task, we choose to train and validate the classic convolutional neural network (CNN) Resnet50. We calculated tumor density and TiLs density in the tumor region (T_TiLs), TILs in the peritumoral region (P_TiLs) as well as TiLs density in the stromal region (S_TiLs). Based on the relative position relationship of tumor cells and lymphocytes, we subclassified the TILs spatial patterns into TILs-dominant, TILs-infiltrating, and TILs-circulating. Results Among the enrolled 86 patients, the male to female ratio approached 4:1. In this study, the mean IoU (mIoU) for nuclei segmentation is 0.9369 and the mean Dice coefficient is 0.9209. The areas under curve (AUC) for lymphocyte, tumor cell, and stromal cells classification are 0.92, 0.90 and 0.86, respectively. Through univariate analysis, TILs in tumor region (HR = 1.285, 95% CI: 1.042–1.586, p = 0.019), and TILs spatial organization (HR = 3.652, 95% CI: 1.216–10.967, p = 0.021) were identified as significant prognostic factors for OS. Multivariate analysis further revealed TILs in tumor region as the independent prognostic factor (HR = 1.248, 95% CI: 1.006–1.547, p = 0.044). Discussion The present study indicates that spatial organization and T_TILs are significant prognostic factors for ESCC patients receiving neoadjuvant immunochemotherapy. Future prospective studies with large sample size are needed to further validate the prognostic role of interaction between TILs spatial characteristic and distribution density in predicting overall survival.

Tumour Infiltrating Lymphocytes Correlate with Improved Survival in Patients with Esophageal Squamous Cell Carcinoma.

Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: an Updated Meta-Analysis

Spatial heterogeneity and prognostic significance of TAMs and TILs infiltrates in different staging esophageal squamous carcinoma

Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma

Evaluation of multiple immune cells and patient outcomes in esophageal squamous cell carcinoma

CD103(+) Tumor-Infiltrating Lymphocytes Predict Favorable Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Characterization of LAG-3, CTLA-4, and CD8+ TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma

Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis

Identification of tumor-infiltrating lymphocyte subpopulations correlated with patient prognosis in esophageal squamous cell carcinoma

593. DEEP LEARNING-BASED PROGNOSTIC MODEL INTEGRATING TUMOR-INFILTRATING LYMPHOCYTES FOR ESOPHAGEAL CANCER: A MULTICENTER RETROSPECTIVE COHORT STUDY

The integration of proportion and cell counts of stromal, not intratumoral, PD-1<SUP>+ </SUP>tumor-infiltrating lymphocytes has prognostic significance in esophageal squamous cell carcinoma

Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients

Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma

Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma

367. SPATIAL ORGANIZATION OF TUMOR-INFILTRATING LYMPHOCYTES PREDICTS PROGNOSIS OF PATIENTS WITH ESOPHAGEAL CANCER RECEIVING IMMUNOTHERAPY—A DEEP-LEARNING APPROACH

CD68 and Interleukin 13, Prospective Immune Markers for Esophageal Squamous Cell Carcinoma Prognosis Prediction

Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma

Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma

CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer